|
|
A Mathew, I Kurane, A L Rothman, L L Zeng, M A Brinton, F A Ennis
J Clin Invest. 1996;
98(7):1684
doi:10.1172/JCI118964
Abstract |
Full text
| PDF

A
severe complication of dengue virus infection, dengue hemorrhagic fever (DHF), is hypothesized to be immunologically mediated and virus-specific cytotoxic T lymphocytes (CTLs) may trigger DHF. It is also likely that dengue virus-specific CTLs are important for recovery from dengue virus infections. There is little available information on the human CD8+ T cell responses to dengue viruses. Memory CD8+CTL responses were analyzed to determine the diversity of the T cell response to dengue virus and to identify immunodominant proteins using PBMC from eight healthy adult volunteers who had received monovalent, live-attenuated candidate vaccines of the four dengue serotypes. All the donors had specific T cell proliferation to dengue and to other flaviviruses that we tested. CTLs were generated from the stimulated PBMC of all donors, and in the seven donors tested, dengue virus-specific CD8+CTL activity was demonstrated. The nonstructural (NS3 and NS1.2a) and envelope (E) proteins were recognized by CD8+CTLs from six, five, and three donors, respectively. All donors recognized either NS3 or NS1.2a. In one donor who received a dengue 4 vaccine, CTL killing was seen in bulk culture against the premembrane protein (prM). This is the first demonstration of a CTL response against the prM protein. The CTL responses using the PBMC of two donors were serotype specific, whereas all other donors had serotype-cross-reactive responses. For one donor, CTLs specific for E, NS1.2a, and NS3 proteins were all HLA-B44 restricted. For three other donors tested, the potential restricting alleles for recognition of NS3 were B38, A24, and/or B62 and B35.These results indicate that the CD8+CTL responses of humans after immunization with one serotype of dengue virus are diverse and directed against a variety of proteins. The NS3 and NS1.2a proteins should be considered when designing subunit vaccines for dengue.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(20)
| Title and authors |
Publication |
Year |
Conserved MHC Class I-Presented Dengue Virus Epitopes Identified by Immunoproteomics Analysis Are Targets for Cross-Serotype Reactive T-Cell Response
J. S. Testa, V. Shetty, G. Sinnathamby, Z. Nickens, J. Hafner, S. Kamal, X. Zhang, M. Jett, R. Philip
|
J. Infect. Dis.
|
2012 |
Dengue virus-specific CD4+ and CD8+ T lymphocytes target NS1, NS3 and NS5 in infected Indian rhesus macaques
Katherine M. Mladinich, Shari M. Piaskowski, Richard Rudersdorf, Christopher M. Eernisse, Kim L. Weisgrau, Mauricio A. Martins, Jessica R. Furlott, Charalambos D. Partidos, Joseph N. Brewoo, Jorge E. Osorio, Nancy A. Wilson, Eva G. Rakasz, David I. Watkins
|
Immunogenetics
|
2011 |
A DNA-based West Nile virus replicon elicits humoral and cellular immune responses in mice
Fei Cao, Xiao-Feng Li, Xue-Dong Yu, Yong-Qiang Deng, Tao Jiang, Qing-Yu Zhu, E-De Qin, Cheng-Feng Qin
|
Journal of Virological Methods
|
2011 |
DifferentialIn VivoClearance and Response to Secondary Heterologous Infections by H2b-Restricted Dengue Virus-Specific CD8+T Cells
Coreen M. Beaumier, Smita Jaiswal, Kim Y. West, Heather Friberg, Anuja Mathew, Alan L. Rothman
|
Viral Immunology
|
2010 |
Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology.
Kerrie Vaughan, Jason Greenbaum, Martin Blythe, Bjoern Peters, Alessandro Sette
|
Viral Immunology
|
2010 |
Scientific consultation on cell mediated immunity (CMI) in dengue and dengue vaccine development
Stephen J. Thomas, Joachim Hombach, Alan Barrett
|
Vaccine
|
2009 |
Comprehensive Analysis of West Nile Virus–Specific T Cell Responses in Humans
Marion C. Lanteri, John W. Heitman, Rachel E. Owen, Thomas Busch, Nelly Gefter, Nancy Kiely, Hany T. Kamel, Leslie H. Tobler, Michael P. Busch, Philip J. Norris
|
J INFECT DIS
|
2008 |
Computational prediction and identification of dengue virus-specific CD4+ T-cell epitopes
Jin-Sheng Wen, Li-Fang Jiang, Jun-Mei Zhou, Hui-Jun Yan, Dan-Yun Fang
|
Virus Research
|
2008 |
Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis
Whitney E. Purtha, Nancy Myers, Vesselin Mitaksov, Elizabeth Sitati, Janet Connolly, Daved H. Fremont, Ted H. Hansen, Michael S. Diamond
|
Eur. J. Immunol.
|
2007 |
Preparation and immunogenic properties of a recombinant West Nile subunit vaccine
Michael M. Lieberman, David E. Clements, Steven Ogata, Gordon Wang, Gloria Corpuz, Teri Wong, Tim Martyak, Lynne Gilson, Beth-Ann Coller, Julia Leung, Douglas M. Watts, Robert B. Tesh, Marina Siirin, Amelia Travassos da Rosa, Tom Humphreys, Carolyn Weeks-Levy
|
Vaccine
|
2007 |
|